David Lazar
Listed on 4 Form D filings across 3+ issuers
· Director, Executive Officer
Associated issuers
- KALA BIO, Inc. CIK 1479419 · MA
- Cyclacel Pharmaceuticals, Inc. CIK 1130166 · NJ
- LQR House Inc. CIK 1843165 · FL
Filings (4)
-
KALA BIO, Inc.D · Feb 13, 2026 · MA · Biotechnology$4.2MView filing →
-
Cyclacel Pharmaceuticals, Inc.D · Feb 14, 2025 · NJ · Biotechnology
-
Cyclacel Pharmaceuticals, Inc.D · Feb 14, 2025 · NJ · Biotechnology$25MView filing →
-
LQR House Inc.D · Jan 3, 2025 · FL · Other$22.8MView filing →